JP2022539032A5 - - Google Patents

Info

Publication number
JP2022539032A5
JP2022539032A5 JP2021576554A JP2021576554A JP2022539032A5 JP 2022539032 A5 JP2022539032 A5 JP 2022539032A5 JP 2021576554 A JP2021576554 A JP 2021576554A JP 2021576554 A JP2021576554 A JP 2021576554A JP 2022539032 A5 JP2022539032 A5 JP 2022539032A5
Authority
JP
Japan
Prior art keywords
cells
hspcs
mature
increased
pluripotent stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021576554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039414 external-priority patent/WO2020264019A1/en
Publication of JP2022539032A publication Critical patent/JP2022539032A/ja
Publication of JP2022539032A5 publication Critical patent/JP2022539032A5/ja
Pending legal-status Critical Current

Links

JP2021576554A 2019-06-24 2020-06-24 ヒト胸腺細胞形成およびｔ細胞機能を強化するためのｂｃｌ１１ｂ過剰発現 Pending JP2022539032A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962865835P 2019-06-24 2019-06-24
US62/865,835 2019-06-24
PCT/US2020/039414 WO2020264019A1 (en) 2019-06-24 2020-06-24 Bcl11b overexpression to enhance human thymopoiesis and t cell function

Publications (2)

Publication Number Publication Date
JP2022539032A JP2022539032A (ja) 2022-09-07
JP2022539032A5 true JP2022539032A5 (https=) 2023-07-03

Family

ID=71842851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021576554A Pending JP2022539032A (ja) 2019-06-24 2020-06-24 ヒト胸腺細胞形成およびｔ細胞機能を強化するためのｂｃｌ１１ｂ過剰発現

Country Status (8)

Country Link
US (1) US20220347222A1 (https=)
EP (1) EP3986427A1 (https=)
JP (1) JP2022539032A (https=)
KR (1) KR20220042353A (https=)
CN (1) CN114828876A (https=)
AU (1) AU2020301413A1 (https=)
CA (1) CA3144640A1 (https=)
WO (1) WO2020264019A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574952B (zh) * 2019-09-30 2025-04-15 英基生物医药(香港)有限公司 一种工程化人体免疫细胞、其制备方法及应用
CA3158133A1 (en) 2020-04-28 2021-11-04 Lyell Immunopharma, Inc. Methods for culturing cells
FR3130843A1 (fr) * 2021-12-21 2023-06-23 Universite Claude Bernard Lyon 1 Cellule progéniteur des lymphocytes T exprimant de manière régulée un transgène d’intérêt
WO2025038494A1 (en) * 2023-08-11 2025-02-20 Tune Therapeutics, Inc. Compositions, systems, and methods for lymphoid cell differentiation using targeted gene activation
WO2025097004A1 (en) * 2023-11-02 2025-05-08 Regents Of The University Of Minnesota Modulation of hematopoietic cells using bcl11b
CN118374444A (zh) * 2024-05-24 2024-07-23 中国人民解放军军事科学院军事医学研究院 一种利用骨髓类器官体外生产人血细胞的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2324109B1 (en) * 2008-09-03 2016-10-26 Mesoblast, Inc. Expansion of haemopoietic precursors
CA2776143A1 (en) 2009-10-01 2011-04-07 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
CA2823782C (en) * 2011-01-10 2019-05-07 Samuel Strober Enhancement of allogeneic hematopoietic stem cell transplantation
ES2654060T3 (es) 2011-10-20 2018-02-12 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Receptores de antígenos quiméricos anti-CD22
WO2014165707A2 (en) * 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
SG11201803419PA (en) * 2015-10-30 2018-05-30 The Regents Of The Universtiy Of California Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells
WO2017173551A1 (en) * 2016-04-08 2017-10-12 The Governing Council Of The University Of Toronto Method for generating progenitor t cells from stem and/or progenitor cells and use of same
ES2931530T3 (es) * 2017-02-13 2022-12-30 Hopitaux Paris Assist Publique Método para generar progenitores de células T
IL316257A (en) * 2017-12-22 2024-12-01 Fate Therapeutics Inc Enhanced immune effector cells and use thereof

Similar Documents

Publication Publication Date Title
JP2022539032A5 (https=)
JP7778708B2 (ja) 多能性幹細胞からナチュラルキラー細胞を産生するための方法
US20200121721A1 (en) Methods for genetic modification of hematopoietic cells
Yoneyama et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract–associated lymphoid tissue, in a granulomatous liver disease
AU2005248352B2 (en) Genetically engineered cells for therapeutic applications
US9062287B2 (en) Process for production of natural killer cells
JP2017529081A (ja) 養子ｔ細胞療法のためのセントラルメモリーｔ細胞
BR112020023232A2 (pt) geração de células nk humanas expandidas e primárias de knock-out com o uso de ribonucleoproteínas cas9
JP2022522231A5 (https=)
JP2023519744A5 (https=)
WO2017071173A1 (zh) 经il-12/cd62l融合蛋白改造的肿瘤治疗剂及其制法和用途
JP2021527397A (ja) 造血幹細胞を生成するための方法
CN101580817A (zh) 含有细胞因子诱导杀伤细胞的细胞群的制造方法
CN115066492A (zh) 产生造血干细胞的方法
JP2024513522A5 (https=)
US20210015868A1 (en) Methods of manufacturing genetically-modified lymphocytes
JP7726625B2 (ja) 自家ｔ細胞を用いた多発性硬化症の処置方法
Peng et al. A cultured malignant B-1 line serves as a model for Richter's syndrome.
CN120555517B (zh) 山奈酚在促进基因编辑中的应用
CN103237887A (zh) 胚胎干细胞来源的心肌细胞以及包含所述心肌细胞作为活性成分的细胞治疗剂
JP2022534586A5 (https=)
EP4038180B1 (en) Treatment of chronic granulomatous disease
Kawai et al. Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling
CN113215105B (zh) Elmo2过表达间充质干细胞的构建及其在骨折治疗中的应用
IL322820A (en) Methods for creating primary immune cells